Abstract

The present invention provides compounds S3I-201.1066 (Formula 1) and S3I-201.2096 (Formula 2) as selective Stat3 binding agents that block Stat3 association with cognate receptor pTyr motifs, Stat3 phosphorylation and nuclear translocation, Stat3 transcriptional function, and consequently induced Stat3-specific antitumor cell effects in vitro and antitumor response in vivo.

Document Type

Patent

Patent Number

US 8,895,746 B2

Application Serial Number

14/076,247

Issue Date

11-25-2014

Current Assignee

Joint Assignment w/UCFRF: University of Toronto

Assignee at Issuance

Joint Assignment w/UCFRF: University of Toronto

College

Burnett School of Biomedical Sciences

Department

Biomolecular Science Center

Allowance Date

6-23-2014

Filing Date

11-10-2013

Assignee at Filing

Joint Assignment w/UCFRF: University of Toronto

Filing Type

National Filing Record

Donated

no

Share

COinS